Ambu AS (OTCPK:AMBFF)
$ 19.9 -0.6 (-2.93%) Market Cap: 4.14 Bil Enterprise Value: 4.14 Bil PE Ratio: 123.69 PB Ratio: 5.18 GF Score: 97/100

Ambu A/S at JPMorgan Healthcare Conference Transcript

Jan 11, 2023 / 01:15AM GMT
Release Date Price: $12.13
David James Adlington
JPMorgan Chase & Co, Research Division - Head of Medical Technology and Services Equity Research

Perfect. Good afternoon, everybody. I'm David Adlington. I head up the research team for European MedTech for JP. It's my pleasure to introduce Britt Meelby Jensen from Ambu. There will be a Q&A session afterwards.

But with that very short introduction, Britt, over to you.

Britt Meelby Jensen;S;CEO
Ambu A

/-

Thank you, David, and good late afternoon, everyone. I've been looking forward. It's not my first time at the conference, but the first time proudly presenting Ambu and the Ambu story to you guys.

So at Ambu, we have an 85-year history, and we have a long tradition of focusing on rethinking health care together with our customers, and that's really what we do to improve and save lives of our patients. Last year, we helped over 100 million patients worldwide.

So we are Danish-based company. Last year, we had over USD 600 million in revenue. Over the past 5 years, we've

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot